These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 22795807

  • 1. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
    Ori Y, Herman-Edelstein M, Zingerman B, Rozen-Zvi B, Gafter U, Malachi T, Gafter-Gvili A.
    Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
    [Abstract] [Full Text] [Related]

  • 2. Effect of immunosuppressive drugs on DNA repair in human peripheral blood mononuclear cells.
    Herman-Edelstein M, Rozen-Zvi B, Zingerman B, Lichtenberg S, Malachi T, Gafter U, Ori Y.
    Biomed Pharmacother; 2012 Mar; 66(2):111-5. PubMed ID: 22244961
    [Abstract] [Full Text] [Related]

  • 3. Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus.
    Lamoureux F, Picard N, Boussera B, Sauvage FL, Marquet P.
    Fundam Clin Pharmacol; 2012 Aug; 26(4):463-72. PubMed ID: 21631587
    [Abstract] [Full Text] [Related]

  • 4. Different profile of gene expression of cytokines in peripheral blood mononuclear cells of transplant recipients treated with m-TOR inhibitor and calcineurin inhibitor.
    Niemczyk M, Zegarska J, Pawłowska M, Wyzgał J, Ciszek M, Paczek L.
    Transpl Immunol; 2009 Jan; 20(3):139-42. PubMed ID: 18834941
    [Abstract] [Full Text] [Related]

  • 5. Everolimus and sirolimus antagonize tacrolimus based calcineurin inhibition via competition for FK-binding protein 12.
    van Rossum HH, Romijn FP, Smit NP, de Fijter JW, van Pelt J.
    Biochem Pharmacol; 2009 Apr 01; 77(7):1206-12. PubMed ID: 19154728
    [Abstract] [Full Text] [Related]

  • 6. Low-dose calcineurin inhibitor regimen combined with mammalian target of rapamycin inhibitors preserves kidney functions in renal transplant recipients without allograft nephropathy.
    Kacar S, Gurkan A, Karaca C, Varılsuha C, Tilif S.
    Transplant Proc; 2010 Nov 01; 42(9):3513-6. PubMed ID: 21094806
    [Abstract] [Full Text] [Related]

  • 7. Impact of calcineurin inhibitors on urinary excretion of mycophenolic acid and its glucuronide in kidney transplant recipients.
    Naito T, Mino Y, Otsuka A, Ushiyama T, Ito T, Ozono S, Kagawa Y, Kawakami J.
    J Clin Pharmacol; 2009 Jun 01; 49(6):710-8. PubMed ID: 19451405
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporin A, but not everolimus, inhibits DNA repair mediated by calcineurin: implications for tumorigenesis under immunosuppression.
    Thoms KM, Kuschal C, Oetjen E, Mori T, Kobayashi N, Laspe P, Boeckmann L, Schön MP, Emmert S.
    Exp Dermatol; 2011 Mar 01; 20(3):232-6. PubMed ID: 21323745
    [Abstract] [Full Text] [Related]

  • 9. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, Malachi T, Gafter U.
    J Lab Clin Med; 2001 Jan 01; 137(1):14-20. PubMed ID: 11150019
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M, Yano I, Masuda S, Fukatsu S, Katsura T, Ogura Y, Oike F, Takada Y, Tanaka K, Inui K.
    Clin Pharmacol Ther; 2005 Aug 01; 78(2):168-81. PubMed ID: 16084851
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
    Hoogduijn MJ, Crop MJ, Korevaar SS, Peeters AM, Eijken M, Maat LP, Balk AH, Weimar W, Baan CC.
    Transplantation; 2008 Nov 15; 86(9):1283-91. PubMed ID: 19005411
    [Abstract] [Full Text] [Related]

  • 12. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
    Patsenker E, Schneider V, Ledermann M, Saegesser H, Dorn C, Hellerbrand C, Stickel F.
    J Hepatol; 2011 Aug 15; 55(2):388-98. PubMed ID: 21168455
    [Abstract] [Full Text] [Related]

  • 13. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
    Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL, Kobashigawa J.
    Circulation; 2004 Dec 21; 110(25):3858-65. PubMed ID: 15611389
    [No Abstract] [Full Text] [Related]

  • 14. Effect of different immunosuppressive drugs on immune cells from young and old healthy persons.
    Welzl K, Kern G, Mayer G, Weinberger B, Säemann MD, Sturm G, Grubeck-Loebenstein B, Koppelstaetter C.
    Gerontology; 2014 Dec 21; 60(3):229-38. PubMed ID: 24434865
    [Abstract] [Full Text] [Related]

  • 15. DNA repair in mononuclear cells: role of serine/threonine phosphatases.
    Herman M, Ori Y, Chagnac A, Weinstein T, Korzets A, Zevin D, Malachi T, Gafter U.
    J Lab Clin Med; 2002 Oct 21; 140(4):255-62. PubMed ID: 12389024
    [Abstract] [Full Text] [Related]

  • 16. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.
    Dieterlen MT, Bittner HB, Klein S, von Salisch S, Mittag A, Tárnok A, Dhein S, Mohr FW, Barten MJ.
    Cytometry B Clin Cytom; 2012 May 21; 82(3):151-7. PubMed ID: 22213594
    [Abstract] [Full Text] [Related]

  • 17. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Bergh CH.
    Transplantation; 2010 Apr 15; 89(7):864-72. PubMed ID: 20061999
    [Abstract] [Full Text] [Related]

  • 18. Clinical insights for cancer outcomes in renal transplant patients.
    Alberú J.
    Transplant Proc; 2010 Nov 15; 42(9 Suppl):S36-40. PubMed ID: 21095450
    [Abstract] [Full Text] [Related]

  • 19. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.
    Liver Transpl; 2009 Dec 15; 15(12):1792-7. PubMed ID: 19938140
    [Abstract] [Full Text] [Related]

  • 20. Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005.
    Chang SH, Russ GR, Chadban SJ, Campbell S, McDonald SP.
    Nephrology (Carlton); 2008 Apr 15; 13(2):171-6. PubMed ID: 18275507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.